Transcarent Appoints Snezana Mahon as Chief Operating Officer

Mahon joins after a successful career as an executive at Evernorth and Express Scripts; will add significant experience in product, pharmacy, and value-based care and will help manage growth

SAN FRANCISCO–(BUSINESS WIRE)–Transcarent, a health and care experience company for employees of self-insured employers and their families, announced today the appointment of Snezana Mahon, Pharm.D., as Chief Operating Officer. Ms. Mahon will report to Transcarent Executive Chairman and Chief Executive Officer, Glen Tullman.


Ms. Mahon brings deep expertise in product development, pharmacy benefits management, and value-based care, having spent her career advancing innovative clinical initiatives and utilization management programs at Express Scripts and more recently, Evernorth, a division of Cigna, helping to make the use of prescription medications safer, more affordable, and more accessible for patients.

“We are excited to welcome Snezana to our expanding leadership team,” said Tullman. “With her extensive product development and operational experience in managing innovative clinical initiatives, I’m confident that she is the right leader to help guide and scale Transcarent’s mission of creating a better and different experience for employees and their families, measurably improving care, and making that care more affordable.”

Most recently, Ms. Mahon was Vice President and General Manager of Care Solutions at Evernorth. Prior to Evernorth, Mahon was Vice President and General Manager of clinical and trend solutions at Express Scripts, where she led the company’s clinical initiatives and utilization management programs. Previously, Ms. Mahon was Senior Director of Medicare strategy at Express Scripts, where she guided Medicare Advantage and Part D plans on CMS guidelines, regulations, and Star Ratings requirements. She is a registered pharmacist and holds a doctorate in pharmacy from the St. Louis College of Pharmacy.

“I’m looking forward to joining Transcarent at this incredible time not only in the company’s growth, but at a time when the entire industry is re-thinking what it means to deliver high value healthcare in America and provide consumers with a new health and care experience,” said Mahon. “Transcarent is putting employers and employees back in charge of their health and care and I intend to put my experience to work to further Transcarent’s mission to improve the quality and value of care for employees and their families.”

Transcarent delivers a personalized, 24/7 care experience, addressing virtually all of the most common and most challenging issues a person faces by connecting them with a personal Health Guide or physician via chat in 60 seconds, phone, or video, offers expert second opinions, medication review and management, virtual physical therapy, and comprehensive appropriate site-of-care surgery solutions. Transcarent is empowering Members to take control of their health and care with easy access that meets them where they are. Members can easily engage Transcarent’s Health Guides and clinical teams for unbiased information, trusted guidance to better understand care options and associated costs, and easy access to high-value virtual and in-person care.

In June 2021, Transcarent closed a $58 million Series B investment led by General Catalyst and 7wireVentures, with participation from Merck Global Health Innovation Fund, Kleiner Perkins, Leaps by Bayer, GreatPoint Ventures, and Threshold Ventures along with existing investors Alta Partners and Jove Equity Partners. This round brings Transcarent’s total funding to $98 million, allowing the company to respond to the demand for rapid expansion of its innovative risk-based offering for self-insured employers.

For more Information, visit us at www.Transcarent.ai and follow us on Twitter or LinkedIn.

About Transcarent

Transcarent is a new and different health and care experience company putting people back in charge of their health and care. Using a combination of software, technology, Health Guides, and data science, Transcarent empowers consumers with the kind of unbiased information, trusted guidance and access to high-value care that leads to better care, better outcomes, and more cost-effective decisions and allows Members to share in the benefits of their decisions. Transcarent believes that having the right information, tools, and incentives in the decision-making process can positively transform the way we all experience our health and care. For more Information, visit us at www.Transcarent.ai and follow us on Twitter or LinkedIn.

Contacts

John Hallock

617-615-7712

Press@transcarent.ai